Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|10|2|215-234

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.10, Iss.2, 2011-03, pp. : 215-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis

By  

Current Cancer Drug Targets, Vol. 12, Iss. 1, 2012-01 ,pp. : 23-43

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Angiogenesis in Ischemic Heart Disease: Gene or Recombinant Vascular Growth Factor Protein Therapy?

By  

Current Gene Therapy, Vol. 3, Iss. 3, 2003-06 ,pp. : 197-206

Bentham Science Publishers

Access to resources Recommend Favorite

Inducible Nitric Oxide Synthase-Vascular Endothelial Growth Factor Axis: A Potential Target to Inhibit Tumor Angiogenesis by Dietary Agents

By  

Current Cancer Drug Targets, Vol. 7, Iss. 5, 2007-08 ,pp. : 475-483

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Development of Angiogenesis Inhibitors to Vascular Endothelial Growth Factor and Its Receptors as Cancer Therapeutics

By  

Current Cancer Drug Targets, Vol. 2, Iss. 2, 2002-06 ,pp. : 135-156

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Angiogenesis using Hepatocyte Growth Factor (HGF)

By  

Current Gene Therapy, Vol. 4, Iss. 2, 2004-06 ,pp. : 199-206

Bentham Science Publishers

Access to resources Recommend Favorite